Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

Overview of attention for article published in International Journal of Hematology, February 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 29 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 978 followers.

FLAGM for R/R AML https://t.co/0qDqgUlDWu

09 Feb 2019

Reply Repost Favourite

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia | SpringerLink https://t.co/G0awI42Tmw

08 Feb 2019

Reply Repost Favourite